Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arginine-stimulated Indication of Early Outcome After Islet Transplantation

NCT05540197 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05540197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arginine-stimulated Indication of Early Outcome After Islet Transplantation
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 23, 2023
Completion date
October 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, diabetes mellitus, islets of langerhans transplantation